Application Nr Approved Date Route Status External Links
ANDA075151 2000-04-25 Intramuscular RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Magnesium Sulfate Injection, Usp Is Suitable For Replacement Therapy In Magnesium Deficiency, Especially In Acute Hypomagnesemia Accompanied By Signs Of Tetany Similar To Those Observed In Hypocalcemia. In Such Cases, The Serum Magnesium (mg++) Level Is Usually Below The Lower Limit Of Normal (1.5 To 2.5 Meq/liter) And The Serum Calcium (ca++) Level Is Normal (4.3 To 5.3 Meq/liter) Or Elevated. In Total Parenteral Nutrition (tpn), Magnesium Sulfate May Be Added To The Nutrient Admixture To Correct Or Prevent Hypomagnesemia Which Can Arise During The Course Of Therapy. Magnesium Sulfate Injection, Usp Is Also Indicated As A Parenteral Anticonvulsant For The Prevention And Control Of Seizures (convulsions) In Severe Toxemia Of Pregnancy. It Effectively Prevents And Controls The Convulsions Of Eclampsia Without Producing Deleterious Depression Of The Central Nervous System Of The Mother Or Infant. However, Other Effective Drugs Are Available For This Purpose.

All Formulated Excipients (0 Total)


Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Magnesium Sulfate Heptahydrate